15.05.2019
- A coalition of 44 US states has filed a 500-page lawsuit against 20 leading generic drugmakers supplying the domestic market. The companies are accused of operating a sweeping...
30.11.2017
- In a provisional ruling announced on Nov. 21, the UK’s Competition and Markets Authority (CMA) has found that Canadian pharma Concordia abused its dominant position to overcharge...
08.08.2017
- As its financial woes continue to deepen, Israeli generics producer Teva is making plans to lay off 7,000 employees and close 15 plants. CEO Yitzhak Peterburg said the company will...
14.07.2017
- The UK Supreme Court has ruled in favor of US drugmaker Eli Lilly in a patent dispute with generics producer Actavis, now owned by Israel’s Teva, over the cancer drug Alimta. The...
09.03.2017
- The UK’s Competition and Markets Authority (CMA) has accused Concordia and Actavis UK of breaking competition law by agreeing to delay competition and keeping the price of...
09.12.2016
- Shares of Israeli drugmaker Teva took a hit earlier this week when the company announced that its generics CEO, Siggi Olafsson, was leaving the company and would be replaced by...
17.10.2016
- Pifzer has lost its appeal of a UK patent dispute with Allergan over Lyrica, one of the US pharmaceutical giant blockbuster drugs, with annual global sales of around $5 billion. It...
07.10.2016
- Israel’s Teva Pharmaceutical Industries is planning to sell the assets of Actavis Generics in the UK and Ireland to Accord Healthcare, a subsidiary of India’s Intas Pharmaceuticals...
